Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
This is the course webpage for Math304, Department of Mathematics, Simon Fraser University. Spring 2021. In this course we will investigate Rubik's cube, the 15-puzzle, TopSpin, and other permutation ...